WellsCare Expands IASO Wearable Cold-Laser Therapy to Thailand Through Strategic Partnership
核心洞察
WellsCare Inc. (搜索) has signed an exclusive supply agreement with SolnanoMed Co., Ltd. (搜索) to distribute its IASO (搜索) cold-laser therapy devices throughout Thailand's healthcare market.
The partnership follows WellsCare's recent FDA Thai approval for its flagship IASO (搜索) Coldlaser, an advanced photobiomodulation therapy device designed for drug-free pain management.
The IASO (搜索) Series utilizes low-level laser light to stimulate cellular recovery and reduce inflammation without medication or side effects, offering hands-free wearable treatment.
WellsCare Inc. (搜索), a South Korean medical technology company, has secured a strategic partnership to expand its wearable cold-laser therapy devices into Thailand's healthcare market. The company announced a supply agreement with SolnanoMed Co., Ltd. (搜索), positioning the Thai distributor as the exclusive partner for WellsCare's IASO (搜索) product line throughout the country.
The partnership comes following WellsCare's recent FDA Thai approval for its flagship IASO (搜索) Coldlaser, an advanced photobiomodulation (PBM) therapy device designed for effective, drug-free pain management. This regulatory milestone enables the company to enter one of Southeast Asia's fastest-growing healthcare markets.
Photobiomodulation Technology for Pain Management
WellsCare's IASO (搜索) Series harnesses low-level laser light to stimulate cellular recovery, reduce inflammation, and alleviate pain without medication or side effects. The technology represents a departure from traditional therapy devices through its compact, hands-free design that allows users to receive continuous PBM treatment anytime, anywhere.
"The Thai healthcare market is rapidly evolving, with growing demand for non-invasive and home-use medical technologies," said Sungwon Lee, CEO of WellsCare. "By collaborating with SolnanoMed, we're bringing our clinically proven laser therapy to more people who seek safe, effective, and portable pain management solutions."
Product Portfolio and Distribution Strategy
The partnership will introduce two key products to the Thai market. The standard IASO (搜索) device provides the core photobiomodulation therapy capabilities, while the IASO Ultra (搜索), WellsCare's premium model, offers enhanced laser output, app connectivity, and multi-zone coverage. This premium version is designed to redefine how patients manage chronic and acute pain at home.
SolnanoMed will serve as WellsCare's exclusive distributor in Thailand, covering hospitals, clinics, and retail channels nationwide. The collaboration aims to make hospital-grade pain-relief technology accessible for everyday users, empowering both healthcare professionals and consumers with convenient, wearable PBM solutions.
Market Expansion and Recognition
WellsCare has positioned itself as a leader in wearable healthcare solutions for patients with musculoskeletal and neurological conditions. The company has received award-winning recognition from international platforms such as CES and iF Design, supporting its expansion efforts across North America and Asia through strategic partnerships and regulatory milestones.
Founded in Seoul, South Korea, WellsCare Inc. (搜索) developed what it describes as the world's first hands-free, wearable cold laser pain relief device. The company's mission centers on delivering safe, non-invasive, and science-backed pain relief to users worldwide, leveraging photobiomodulation technology as its core therapeutic approach.